CSL Seqirus, a Global Leader in Pandemic Preparedness, Announces Fifth BARDA Award in Response to Avian Influenza Outbreak [Yahoo! Finance]
CSL LTD SP/ADR (CSLLY)
NASDAQ:AMEX Investor Relations:
csl.com/investors
Company Research
Source: Yahoo! Finance
MF59 ® adjuvant is an important part of pandemic preparedness planning as it reduces the amount of antigen required to produce an immune response, increasing the number of vaccine doses. When combined with influenza antigens in a vaccine, MF59 ® adjuvant is designed to enhance and broaden the body's immune response by creating a broad, cross-reactive antibody response. "Once again, we're honored to partner with BARDA on pandemic preparedness," said Marc Lacey , CSL Seqirus, Global Executive Director for Pandemic. "This expanded program will increase outbreak resilience and help to protect against threats such as avian influenza." Under the terms of the $121.4 million multi-year award, CSL Seqirus will deliver MF59 ® adjuvant to increase the inventory of the VMI program to 40 million equivalent doses. MF59 ® will be manufactured at CSL Seqirus' Holly Springs, North Carolina facility, which was built under a long-term public-private partnership with BARDA to provide domestic influe
Show less
Read more
Impact Snapshot
Event Time:
CSLLY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CSLLY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CSLLY alerts
High impacting CSL LTD SP/ADR news events
Weekly update
A roundup of the hottest topics
CSLLY
News
- Transforming pharmaceutical R&D: the impact of digital technologies on drug discovery and development [Yahoo! Finance]Yahoo! Finance
- New Data Presented at IDWeek 2024 Show Adjuvanted and High-Dose Influenza Vaccines are Comparable in Protecting Adults 65 Years of Age and Older Against Seasonal InfluenzaPR Newswire
- CSL Seqirus Presents Data at IDWeek 2024 Highlighting the Urgent Need to Increase Influenza Vaccination Rates and the Benefits of Cell-Based Influenza VaccinesPR Newswire
- Pharmanovia Acquires Exclusive Rights to Treatment for Parkinson’s DiseaseBusiness Wire
- CSL Seqirus, a Global Leader in Pandemic Preparedness, Announces Sixth BARDA Award in Response to Avian InfluenzaPR Newswire